B of A Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $84

Benzinga · 04/25/2025 13:03
B of A Securities analyst Craig Bijou maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $104 to $84.